Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Kelly Yoshimi Kanamori"'
Publikováno v:
Repositório Institucional da USP (Biblioteca Digital da Produção Intelectual)
Universidade de São Paulo (USP)
instacron:USP
Universidade de São Paulo (USP)
instacron:USP
Mast cell activation disorders (MCADs) consist of episodic systemic symptoms due to mast cell mediator release. Diagnosis is based on clinical presentation and determination of high levels of tryptase or histamine. Ehlers-Danlos syndrome (EDS) and po
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a42b7683929ce1ce3d8224a2dd0830b5
Autor:
Antonio Abilio Motta, Rosana Câmara Agondi, Jorge Kalil, Carolina Tavares Alcantara, Kelly Yoshimi Kanamori
Publikováno v:
Journal of Allergy and Clinical Immunology. 137:AB258
Autor:
Carolina Tavares De Alcântara, Nathalia Siqueira Robert De Castro, Jorge Kalil, Rosana Câmara Agondi, Kelly Yoshimi Kanamori, Marcelo Vivolo Aun, Bruna Gama Saliba, Carla Bisaccioni, Pedro Giavina-Bianchi
Publikováno v:
The World Allergy Organization Journal
Methods Cross-sectional study that evaluated 193 elderly patients with asthma followed at an outpatient tertiary service. Patients were considered when asthma met the criteria of GINA 2012 anamnesis and pulmonary function demonstrating reversibility.
Autor:
Jorge Kalil, Carolina Tavares De Alcântara, Marcelo Vivolo Aun, Nathalia Siqueira Robert De Castro, Kelly Yoshimi Kanamori, Antonio Abilio Motta
Publikováno v:
The World Allergy Organization Journal
Background Nonsteroidal antiinflammatory drugs (NSAIDs) and antibiotics are widely used drugs and are the leading causes of adverse drug reaction (ADR), especially skin reactions. The photosensitizing effects of piroxicam are known for a long time an
Autor:
Pedro Giavina-Bianchi, Kelly Yoshimi Kanamori, Nathalia Pessoa Simis, Cem Akin, Mariana Castells
Publikováno v:
The World Allergy Organization Journal
Background Mastocytosis is a group of heterogeneous diseases characterized by an abnormal expansion and accumulation of mast cells (MCs) in different tissues. While systemic mastocytosis (SM) is defined by the accumulation of MCs in bone marrow (BM)